GenSight Biologics Future Growth
Future criteria checks 2/6
GenSight Biologics's earnings are forecast to decline at 10% per annum while its annual revenue is expected to grow at 21.9% per year. EPS is expected to decline by 11.9% per annum.
Key information
-10.0%
Earnings growth rate
-11.9%
EPS growth rate
| Biotechs earnings growth | 19.0% |
| Revenue growth rate | 21.9% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 07 May 2024 |
Recent future growth updates
Recent updates
Is There An Opportunity With GenSight Biologics S.A.'s (EPA:SIGHT) 30% Undervaluation?
Dec 22
Is GenSight Biologics S.A. (EPA:SIGHT) Trading At A 39% Discount?
Sep 20Health Check: How Prudently Does GenSight Biologics (EPA:SIGHT) Use Debt?
Aug 17Rock star Growth Puts GenSight Biologics (EPA:SIGHT) In A Position To Use Debt
Aug 04GenSight Biologics S.A. (EPA:SIGHT) Shares Could Be 27% Below Their Intrinsic Value Estimate
Jun 14GenSight Biologics S.A. (EPA:SIGHT): Is Breakeven Near?
May 10Analysts Expect Breakeven For GenSight Biologics S.A. (EPA:SIGHT) Before Long
Feb 02A Quick Analysis On GenSight Biologics' (EPA:SIGHT) CEO Salary
Dec 09
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 6 | -36 | -38 | -38 | 1 |
| 12/31/2025 | 7 | -26 | -28 | -28 | 1 |
| 12/31/2024 | 4 | -26 | -28 | -28 | 1 |
| 12/31/2023 | 3 | -26 | -25 | -25 | N/A |
| 9/30/2023 | 3 | -28 | -29 | -29 | N/A |
| 6/30/2023 | 3 | -29 | -33 | -33 | N/A |
| 3/31/2023 | 4 | -28 | -34 | -34 | N/A |
| 12/31/2022 | 5 | -28 | -34 | -34 | N/A |
| 9/30/2022 | 5 | -29 | -29 | -29 | N/A |
| 6/30/2022 | 5 | -31 | -24 | -24 | N/A |
| 3/31/2022 | 6 | -30 | -20 | -20 | N/A |
| 12/31/2021 | 8 | -29 | -17 | -17 | N/A |
| 9/30/2021 | 9 | -28 | -18 | -18 | N/A |
| 6/30/2021 | 11 | -28 | -19 | -19 | N/A |
| 3/31/2021 | 9 | -31 | -17 | -17 | N/A |
| 12/31/2020 | 7 | -34 | -15 | -15 | N/A |
| 9/30/2020 | 7 | -31 | -15 | -15 | N/A |
| 6/30/2020 | 6 | -28 | -15 | -15 | N/A |
| 3/31/2020 | 5 | -30 | -22 | -22 | N/A |
| 12/31/2019 | 5 | -31 | -28 | -28 | N/A |
| 9/30/2019 | 5 | -35 | -32 | -31 | N/A |
| 6/30/2019 | 5 | -39 | -35 | -35 | N/A |
| 3/31/2019 | 5 | -36 | -32 | -32 | N/A |
| 12/31/2018 | 4 | -33 | -29 | -28 | N/A |
| 9/30/2018 | 4 | -30 | -25 | -25 | N/A |
| 6/30/2018 | 4 | -26 | -21 | -21 | N/A |
| 3/31/2018 | 4 | -25 | -20 | -20 | N/A |
| 12/31/2017 | 4 | -24 | -19 | -19 | N/A |
| 9/30/2017 | 3 | -23 | N/A | -19 | N/A |
| 6/30/2017 | 3 | -23 | N/A | -20 | N/A |
| 3/31/2017 | 3 | -22 | N/A | -20 | N/A |
| 12/31/2016 | 3 | -22 | N/A | -20 | N/A |
| 9/30/2016 | 3 | -20 | N/A | -18 | N/A |
| 6/30/2016 | 4 | -18 | N/A | -17 | N/A |
| 3/31/2016 | 4 | -16 | N/A | -15 | N/A |
| 12/31/2015 | 4 | -14 | N/A | -12 | N/A |
| 9/30/2015 | 3 | -11 | N/A | -10 | N/A |
| 6/30/2015 | 2 | -9 | N/A | -7 | N/A |
| 3/31/2015 | 2 | -8 | N/A | -6 | N/A |
| 12/31/2014 | 1 | -7 | N/A | -6 | N/A |
| 12/31/2013 | 1 | -3 | N/A | -2 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: SIGHT is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: SIGHT is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: SIGHT is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: SIGHT's revenue (21.9% per year) is forecast to grow faster than the French market (5.8% per year).
High Growth Revenue: SIGHT's revenue (21.9% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if SIGHT's Return on Equity is forecast to be high in 3 years time